10 High Growth Forever Dividend Stocks To Invest In

7. Merck & Co. Inc. (NYSE:MRK)

5-Year Revenue Growth: 10.40%

Merck & Co. Inc. (NYSE:MRK) is an American multinational pharmaceutical company, based in New Jersey. It stands out as a major pharmaceutical company with a diverse portfolio of treatments, though its main focus is in oncology. Its top product, Keytruda, ranked as the world’s best-selling cancer drug last year. While US patent protection for Keytruda is set to expire in 2028, Merck is working on a new subcutaneous version of the drug, which could help prolong its market exclusivity into the 2030s.

Merck & Co. Inc. (NYSE:MRK) posted solid financial results in the final quarter of 2024, with revenue climbing 7% year-over-year to $15.6 billion. Over the full year, sales of Keytruda jumped 18%, totaling $29.5 billion. With expectations for the drug to bring in more than $35 billion annually by 2028—just before its patent runs out—the company continues to strengthen its leadership in the immunotherapy space.

Merck & Co. Inc. (NYSE:MRK) is also a solid dividend payer. It currently offers a quarterly dividend of $0.81 per share and has a dividend yield of 4.09%, as of April 13. It is one of the best high growth forever dividend stocks on our list as the company has been rewarding shareholders with growing dividends for the past 14 years.